{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:17:12Z","timestamp":1792603032550,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.schres.2017.01.036","type":"journal-article","created":{"date-parts":[[2017,1,28]],"date-time":"2017-01-28T06:01:41Z","timestamp":1485583301000},"page":"89-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Clozapine and long-acting injectable antipsychotic combination: A retrospective one-year mirror-image study"],"prefix":"10.1016","volume":"188","author":[{"given":"Lama","family":"Souaiby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Odile","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Advenier-Iakovlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2017.01.036_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition: DSM-5","author":"Association, A.P","year":"2013"},{"key":"10.1016\/j.schres.2017.01.036_bb0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/11587810-000000000-00000","article-title":"Antipsychotic polypharmacy in schizophrenia: benefits and risks","volume":"25","author":"Barnes","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2017.01.036_bb0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-244X-12-42","article-title":"Antipsychotic polypharmacy in a regional health service: a population-based study","volume":"12","author":"Bernardo","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2017.01.036_bb0020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/schbul\/16.4.551","article-title":"Defining treatment refractoriness in schizophrenia","volume":"16","author":"Brenner","year":"1990","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2017.01.036_bb0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1440-1614.2003.01092.x","article-title":"Costs of schizophrenia and other psychoses in urban Australia: findings from the Low Prevalence (Psychotic) Disorders Study","volume":"37","author":"Carr","year":"2003","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.036_bb0030","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/00048670701579025","article-title":"Australian Schizophrenia Care and Assessment Programme: real-world schizophrenia: economics","volume":"41","author":"Fitzgerald","year":"2007","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.036_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eurpsy.2005.12.001","article-title":"Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia","volume":"21","author":"Haro","year":"2006","journal-title":"Eur. Psychiatry J. Assoc. Eur. Psychiatr."},{"key":"10.1016\/j.schres.2017.01.036_bb0040","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/2045125312474019","article-title":"Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review","volume":"3","author":"Higashi","year":"2013","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.schres.2017.01.036_bb0045","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"issue":"Suppl. 12","key":"10.1016\/j.schres.2017.01.036_bb0050","first-page":"5","article-title":"The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary","volume":"64","author":"Kane","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.036_bb0055","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4088\/JCP.13r08440","article-title":"Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies","volume":"74","author":"Kishimoto","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.036_bb0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.schres.2010.11.020","article-title":"Oral versus depot antipsychotic drugs for schizophrenia\u2013a critical systematic review and meta-analysis of randomised long-term trials","volume":"127","author":"Leucht","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.01.036_bb0065","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/schbul\/sbj067","article-title":"Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia","volume":"32","author":"Lewis","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2017.01.036_bb0070","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1176\/ajp.151.12.1744","article-title":"Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome","volume":"151","author":"Lieberman","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.036_bb0075","doi-asserted-by":"crossref","first-page":"30S","DOI":"10.1177\/088740341305805s05","article-title":"Long-acting injectable antipsychotics: recommendations for clinicians","volume":"58","author":"Malla","year":"2013","journal-title":"Can. J Psychiatr. Rev. Can. Psychiatr."},{"key":"10.1016\/j.schres.2017.01.036_bb0080","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.01.036_bb0085","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1177\/0269881109348174","article-title":"The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series","volume":"24","author":"Kim","year":"2010","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"10.1016\/j.schres.2017.01.036_bb0090","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/WNF.0000000000000191","article-title":"A case of resistant schizophrenia successfully treated with clozapine\/long-acting injectable aripiprazole combination","volume":"39","author":"Sepede","year":"2016","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.schres.2017.01.036_bb0095","series-title":"Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","author":"Stahl","year":"2013"},{"key":"10.1016\/j.schres.2017.01.036_bb0100","series-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor","year":"2015"},{"key":"10.1016\/j.schres.2017.01.036_bb0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-0447.2011.01792.x","article-title":"Augmentation of clozapine with a second antipsychotic - a meta-analysis","volume":"125","author":"Taylor","year":"2012","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2017.01.036_bb0110","series-title":"le Dictionnaire","author":"Vidal","year":"2015"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641730049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641730049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T00:16:05Z","timestamp":1536365765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099641730049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":22,"alternative-id":["S092099641730049X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.01.036","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine and long-acting injectable antipsychotic combination: A retrospective one-year mirror-image study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.01.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}